Alliance Pharma PLC Notification of Major Interest in Shares (6866B)
05 April 2017 - 10:30PM
UK Regulatory
TIDMAPH TIDMAV.
RNS Number : 6866B
Alliance Pharma PLC
05 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
------------------------------------------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying Alliance Pharma plc
issuer
of existing shares to which voting rights
are
attached:
-------------------------------------------------------------- --------------------------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
------------------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
------------------------------------------------------------------ ----------------------------------------------------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
------------------------------------------------------------------ ----------------------------------------------------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
------------------------------------------------------------------ ----------------------------------------------------
An event changing the breakdown of voting rights
------------------------------------------------------------------ ----------------------------------------------------
Other (please specify):
---------------------------------------------------------- ------ ----------------------------------------------------
3. Full name of person(s) subject Aviva plc & its subsidiaries
to the
notification obligation:
------------------------------------------------------------ ----------------------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):
Available on request 18,450*
Chase (GA Group) Nominees Limited 35,223,402*
*denotes direct interest
Chase Nominees Limited 1,165,093
------------------------------------------------------------ ----------------------------------------------------------
5. Date of the transaction and date 3 April 2017
on
which the threshold is crossed
or
reached:
------------------------------------------------------------ ----------------------------------------------------------
6. Date on which issuer notified: 5 April 2017
------------------------------------------------------------ ----------------------------------------------------------
7. Threshold(s) that is/are crossed 8% to 7% Change at Direct Interest
or Level (Box 8A)
reached:
------------------------------------------------------------ ----------------------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
-------------- --------------------------- -----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights
Shares Voting
Rights
-------------- ------------- ------------ -------------- -------------------------- ---------------------
Direct Direct Indirect Direct Indirect
-------------- ------------- ------------ -------------- ----------- ------------- -------- -----------
Ordinary
Shares
GB0031030819 43,574,295* 43,574,295* 36,406,945 35,241,852 1,165,093 7.46% 0.24%
------------- ------------ -------------- ----------- ------------- -------- -----------
* Includes Right to Recall Loaned Shares (108,293)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may rights
instrument be
acquired if the
instrument is
exercised/ converted.
-------------- ------------- ---------------------------- -------------------------- ---------------------
RIGHT TO
RECALL 50,000*
LOANED
SHARES N/A N/A *Direct Interest 0.01%
-------------- ------------- ---------------------------- -------------------------- ---------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments
----------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights
instrument price date Conversion rights instrument
period refers to
------------------ --------- ----------- ------------ ------------------- ---------------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- ----------- --------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
36,456,945 7.71%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
--------------------------------------------------------------------------------------------------------------
The voting rights are managed and controlled by Aviva Investors Global
Services Limited and Friends Provident International Limited, with the
following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Friends Provident International Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
Proxy Voting:
--------------------------------------------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
------------------------------------------------------------- -----------------------------------------------
11. Number of voting rights proxy holder will
cease
to hold:
------------------------------------------------------------- -----------------------------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
------------------------------------------------------------- -----------------------------------------------
13. Additional information: Figures are based on a total number
of voting rights of 472,716,142, as
per the Company's 'Application for admission'
announcement of 14(th) February 2017.
------------------------------------------------------------- -----------------------------------------------
14. Contact name: James Clark, Aviva plc
------------------------------------------------------------- -----------------------------------------------
15. Contact telephone number: 01603 683853
------------------------------------------------------------- -----------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAALSEAFXEFF
(END) Dow Jones Newswires
April 05, 2017 08:30 ET (12:30 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024
